Form 8-K - Current report:
SEC Accession No. 0000950170-25-085144
Filing Date
2025-06-12
Accepted
2025-06-12 08:10:45
Documents
10
Period of Report
2025-06-09
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sprb-20250609.htm   iXBRL 8-K 60683
  Complete submission text file 0000950170-25-085144.txt   177678

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sprb-20250609.xsd EX-101.SCH 31809
12 EXTRACTED XBRL INSTANCE DOCUMENT sprb-20250609_htm.xml XML 4729
Mailing Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080 (415) 655-4168
SPRUCE BIOSCIENCES, INC. (Filer) CIK: 0001683553 (see all company filings)

EIN.: 812154263 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39594 | Film No.: 251041715
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)